Overview
Rogerio Lilenbaum is a Hematologist in New Haven, Connecticut. Dr. Lilenbaum has been practicing medicine for over 36 years is highly rated in 9 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
His clinical research consists of co-authoring 31 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
20 York St, New Haven, CT 06510
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale New Haven Hospital
Amer Zeidan is a Hematologist in New Haven, Connecticut. Dr. Zeidan is highly rated in 24 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Yale New Haven Hospital
Nikolai Podoltsev is a Hematologist in New Haven, Connecticut. Dr. Podoltsev is highly rated in 30 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant.
Yale University
Mario Sznol is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Sznol has been practicing medicine for over 44 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, and WT1-Related Wilms Tumor Syndromes.
Frequently Asked Questions about Dr. Rogerio Lilenbaum
How do I make an appointment with Dr. Rogerio Lilenbaum?
You can book an appointment with Dr. Rogerio Lilenbaum by calling their office at 203-200-2094. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rogerio Lilenbaum a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rogerio Lilenbaum is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rogerio Lilenbaum specialize in?
While Dr. Rogerio Lilenbaum is a Hematology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Rogerio Lilenbaum participate in research or clinical trials?
Yes. Dr. Rogerio Lilenbaum has published 31 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Rogerio Lilenbaum's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rogerio Lilenbaum accept my insurance?
Dr. Rogerio Lilenbaum accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 203-200-2094 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Non-Small Cell Lung Cancer (NSCLC)Dr. Lilenbaum isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Lilenbaum isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Lilenbaum isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Lilenbaum isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Lilenbaum isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Lilenbaum isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Lilenbaum isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Liver CancerDr. Lilenbaum isExperienced. Learn about Liver Cancer.
- MesotheliomaDr. Lilenbaum isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Lilenbaum isExperienced. Learn about Metastatic Brain Tumor.